| Title | siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway |
| Author | |
| Corresponding Author | Lu, Xiaoqing; Xing, Nianzeng |
| Publication Years | 2023-09-01
|
| DOI | |
| Source Title | |
| ISSN | 1479-6694
|
| EISSN | 1744-8301
|
| Volume | 19Issue:30 |
| Abstract | Androgen deprivation therapy is a common treatment method for metastatic prostate cancer through lowering androgen levels; however, this therapy frequently leads to the development of castration-resistant prostate cancer (CRPC). This is attributed to the activation of the androgen receptor (AR) signaling pathway. Current treatments targeting AR are often ineffective mostly due to AR gene overexpression and mutations, as well as the presence of splice variants that accelerate CRPC progression. Thus there is a critical need for more specific medication to treat CRPC. Small interfering RNAs have shown great potential as a targeted therapy. This review discusses prostate cancer progression and the role of AR signaling in CRPC, and proposes siRNA-based targeted therapy as a promising strategy for CRPC. |
| Keywords | |
| URL | [Source Record] |
| Indexed By | |
| Language | English
|
| SUSTech Authorship | Others
|
| Funding Project | National Natural Science Foundation of China["82002820","82172659","82072740"]
|
| WOS Research Area | Oncology
|
| WOS Subject | Oncology
|
| WOS Accession No | WOS:001079325000001
|
| Publisher | |
| Data Source | Web of Science
|
| Citation statistics | |
| Document Type | Journal Article |
| Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/582985 |
| Department | Southern University of Science and Technology |
| Affiliation | 1.Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Shanxi Hosp, Canc Hosp,Shanxi Med Univ, Taiyuan 030001, Peoples R China 2.Southern Univ Sci & Technol, Shenzhen 518000, Peoples R China 3.Shanxi Med Univ, Hosp 3, Shanxi Bethune Hosp, Shanxi Acad Med Sci,Tongji Shanxi Hosp,Dept Urol, Taiyuan 030032, Peoples R China |
| Recommended Citation GB/T 7714 |
Yu, Yanling,Papukashvili, Dimitri,Ren, Ruimin,et al. siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway[J]. FUTURE ONCOLOGY,2023,19(30).
|
| APA |
Yu, Yanling.,Papukashvili, Dimitri.,Ren, Ruimin.,Rcheulishvili, Nino.,Feng, Shunping.,...&Xing, Nianzeng.(2023).siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway.FUTURE ONCOLOGY,19(30).
|
| MLA |
Yu, Yanling,et al."siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway".FUTURE ONCOLOGY 19.30(2023).
|
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
;
Edit Comment